{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:59:35Z","timestamp":1697644775409},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12149-013-0741-5","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T12:30:15Z","timestamp":1370003415000},"page":"737-747","source":"Crossref","is-referenced-by-count":3,"title":["Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson\u2019s and heart diseases"],"prefix":"10.1007","volume":"27","author":[{"given":"Ichiro","family":"Nakae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Mitsunami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"741_CR1","first-page":"1620","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Wieland DM, Sheman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med. 1987;28:1620\u20134.","journal-title":"J Nucl Med"},{"key":"741_CR2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0735-1097(95)00374-6","volume":"26","author":"Y Imamura","year":"1995","unstructured":"Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"741_CR3","first-page":"471","volume":"33","author":"P Merlet","year":"1992","unstructured":"Merlet P, Valette H, Dubois-Rand\u00e9 JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471\u20137.","journal-title":"J Nucl Med"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2005;76:249\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"741_CR5","first-page":"378","volume":"52","author":"K Nakajima","year":"2008","unstructured":"Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging. 2008;52:378\u201387.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"741_CR6","first-page":"2138","volume":"36","author":"G Germano","year":"1995","unstructured":"Germano G, Kavanagh P, Su HT, Mazzanti M, Hiat H, Hachamovich R, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138\u201347.","journal-title":"J Nucl Med"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02985571","volume":"19","author":"I Nakae","year":"2005","unstructured":"Nakae I, Matsuo S, Koh T, Mitsunami K, Horie K. Left ventricular systolic\/diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis. Ann Nucl Med. 2005;19:447\u201354.","journal-title":"Ann Nucl Med"},{"key":"741_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12149-008-0174-8","volume":"22","author":"I Nakae","year":"2008","unstructured":"Nakae I, Matsuo S, Tsutamoto T, Matsumoto T, Mitsunami K, Horie M. Clinical significance of diastolic function as an indicator of myocardial ischemia assessed by 16-frame gated myocardial perfusion SPECT. Ann Nucl Med. 2008;22:677\u201383.","journal-title":"Ann Nucl Med"},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s002590100487","volume":"28","author":"M Kikkawa","year":"2001","unstructured":"Kikkawa M, Nakamura T, Sakamoto K, Sugihara H, Azuma A, Sawada T, et al. Assessment of left ventricular diastolic function from quantitative electrocardiographic-gated 99mTc-tetrofosmin myocardial SPET. Eur J Nucl Med. 2001;28:593\u2013601.","journal-title":"Eur J Nucl Med"},{"key":"741_CR10","first-page":"1102","volume":"46","author":"C Akincioglu","year":"2005","unstructured":"Akincioglu C, Berman DS, Nishina H, Kavanagh PB, Slomka PJ, Abidov A, et al. Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med. 2005;46:1102\u20138.","journal-title":"J Nucl Med"},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12149-009-0337-2","volume":"24","author":"K Nakajima","year":"2010","unstructured":"Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med. 2010;24:125\u201335.","journal-title":"Ann Nucl Med"},{"key":"741_CR12","first-page":"437","volume":"47","author":"KH Lee","year":"2006","unstructured":"Lee KH, Ko BH, Paik JY, Jung KH, Bae JS, Choi JY, et al. Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells. J Nucl Med. 2006;47:437\u201342.","journal-title":"J Nucl Med"},{"key":"741_CR13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00256632","volume":"13","author":"DO Slosman","year":"1988","unstructured":"Slosman DO, Davidson D, Brill AB, Alderson PO. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function. Eur J Nucl Med. 1988;13:543\u201354.","journal-title":"Eur J Nucl Med"},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","volume":"40","author":"W Kuhn","year":"1998","unstructured":"Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, et al. Elevated plasma levels of homocysteine in Parkinson\u2019s disease. Eur Neurol. 1998;40:225\u20137.","journal-title":"Eur Neurol"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","volume":"354","author":"T M\u00fcller","year":"1999","unstructured":"M\u00fcller T, Werne B, Fowler B, Kuhn W. Nigral endothelial dysfunction, homocysteine, and Parkinson\u2019s disease. Lancet. 1999;354:126\u20137.","journal-title":"Lancet"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.100.11.1161","volume":"100","author":"PM Kanani","year":"1999","unstructured":"Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 1999;100:1161\u20138.","journal-title":"Circulation"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.amjcard.2008.01.030","volume":"101","author":"Y Kamiyoshi","year":"2008","unstructured":"Kamiyoshi Y, Yazaki Y, Urushibata K, Koizumu T, Kasai H, Izawa A, et al. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2008;101:1482\u20136.","journal-title":"Am J Cardiol"},{"key":"741_CR18","first-page":"334","volume":"39","author":"S Murashima","year":"1998","unstructured":"Murashima S, Takeda K, Matsumura K, Yamakado K, Sakuma H, Kitano T, et al. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med. 1998;39:334\u20138.","journal-title":"J Nucl Med"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02988344","volume":"15","author":"X Mu","year":"2001","unstructured":"Mu X, Hasegawa S, Yoshioka J, Maruyama A, Maruyama K, Paul AK, et al. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure. Ann Nucl Med. 2001;15:411\u20136.","journal-title":"Ann Nucl Med"},{"key":"741_CR20","first-page":"897","volume":"26","author":"MC Tobes","year":"1985","unstructured":"Tobes MC, Jaques S Jr, Wieland DM, Sisson JC. Effect of uptake one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med. 1985;26:897\u2013907.","journal-title":"J Nucl Med"},{"key":"741_CR21","first-page":"224","volume":"40","author":"P Merlet","year":"1999","unstructured":"Merlet P, Pouillart F, Dubois-Rand\u00e9 JL, Delahaye N, Fumey R, Castaigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med. 1999;40:224\u201331.","journal-title":"J Nucl Med"},{"key":"741_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1253\/jcj.65.155","volume":"65","author":"Y Imamura","year":"2001","unstructured":"Imamura Y, Fukuyama T, Mochizuki T, Miyagawa M, Watanabe K, Ehime MIBG Heart Failure Study Investigators. Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J. 2001;65:155\u201360.","journal-title":"Jpn Circ J"},{"key":"741_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-8703(95)90251-1","volume":"130","author":"DJ Lenihan","year":"1995","unstructured":"Lenihan DJ, Gerson MC, Hoit BD, Walsh RA. Mechanisms, diagnosis, and treatment of diastolic heart failure. Am Heart J. 1995;130:153\u201366.","journal-title":"Am Heart J"},{"key":"741_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0735-1097(97)00144-7","volume":"30","author":"RA Nishimura","year":"1997","unstructured":"Nishimura RA, Tajik JA. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician\u2019s Rosetta stone. J Am Coll Cardiol. 1997;30:8\u201318.","journal-title":"J Am Coll Cardiol"},{"key":"741_CR25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","volume":"124","author":"M Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction. A target of phosphodiesterase-5 inhibition in a 1-year study. Circulation. 2011;124:164\u201374.","journal-title":"Circulation"},{"key":"741_CR26","doi-asserted-by":"crossref","first-page":"72A","DOI":"10.1016\/0735-1097(93)90466-E","volume":"22","author":"JS Floras","year":"1993","unstructured":"Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;22:72A\u201384A.","journal-title":"J Am Coll Cardiol"},{"key":"741_CR27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","volume":"29","author":"HJ Verberne","year":"2008","unstructured":"Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147\u201359.","journal-title":"Eur Heart J"},{"key":"741_CR28","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"741_CR29","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","volume":"98","author":"M Senni","year":"1998","unstructured":"Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282\u20139.","journal-title":"Circulation"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-013-0741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0741-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:24Z","timestamp":1559450484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-013-0741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s12149-013-0741-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}